One-year study of S1B-509 for weight loss
Part of Hormones & metabolism clinical trials.
This one-year study tests whether a new medication called S1B-509 can help people with obesity lose weight when combined with diet and exercise. It compares the study drug to an inactive placebo to see if it works and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have obesity and a related health problem like type 2 diabetes, high blood pressure, or sleep apnea.
- You must not have used any weight-loss prescription drugs, including Ozempic, in the past 3 months.
- You must not have had weight-loss surgery (like gastric bypass) in the past.
- You must agree to follow a healthy lifestyle program and take the study medication for a full year.
- You cannot be taking certain medications for mood, seizures, or sleep, or have certain heart, liver, kidney, or stomach conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an investigational medicine to help people who have lost weight keep it off. It's for adults without diabetes who haven't used similar weight-loss drugs before.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.